Morphine Sulfate
- Product NDC
- 51862-617
- 11-digit product format
- 518620617
- Labeler code
- 51862
- Product ID
- 51862-617_068fb771-cd6b-4e25-aa84-6dae2175d2cb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Morphine Sulfate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mayne Pharma Inc
- Application
- ANDA207270
- Marketing category
- ANDA
- Marketing start
- 2022-01-14
- Marketing end
- 0000-00-00
- Substance
- MORPHINE SULFATE
- Active strength
- 30 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51862-617 | MORPHINE SULFATE TABLET [MAYNE PHARMA COMMERCIAL LLC] | 3 | Legacy NDC | 20230707_6c26431c-5ad1-4c79-9db6-1e8071b2c793.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51862-617-01 | 51862061701 | 100 TABLET in 1 BOTTLE (51862-617-01) | 100 tablet | 2022-01-14 | 0000-00-00 | No | No | Current |